Clinical Trials Directory

Trials / Completed

CompletedNCT01026805

Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

Retrospective Case Review - Clinical Evaluation of the Interlace Medical 1st Generation Hysteroscopic Morcellator

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Hologic, Inc. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study assesses the effectiveness of intrauterine fibroid and polyp removal using the Interlace Medical 1st generation hysteroscopic morcellator device based on a retrospective review of medical records of women who have been treated with the device.

Detailed description

A retrospective review of medical records for eleven (11) premenopausal women who had been treated with the new hysteroscopic morcellator was conducted at four hospital or ambulatory surgical center sites. Four physicians performed hysteroscopic operative procedures to remove intrauterine polyps, type 0 (completely within the uterine cavity), type I (mostly within the cavity) and type II (\< 40% within the cavity) submucous myomas. Percent pathology removed, total morcellation time, total fluid used, fluid deficit and treatment-related adverse events were assessed. Each of the four treating physicians also evaluated device performance using a 10 point scale (1 = "poor" and 10 = "excellent").

Conditions

Interventions

TypeNameDescription
DEVICEInterlace Medical 1st Generation Hysteroscopic MorcellatorThe Interlace Medical hysteroscopic morcellator system has been cleared by the FDA(K073690)and consists of a motor drive unit connected to a 3mm morcellator. The morcellator is approximately 12 cm long and is equipped with an open channel that houses a reciprocating blade. When the motor is activated, the reciprocating blade will cut the tissue within the channel. The tissue travels down the 3mm morcellator shaft cannula via suction coupled to the proximal end of the morcellator and is captured in a tissue trap in a suction canister for pathological diagnosis following the procedure.

Timeline

Start date
2009-02-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2009-12-04
Last updated
2012-11-22
Results posted
2009-12-04

Source: ClinicalTrials.gov record NCT01026805. Inclusion in this directory is not an endorsement.